Azenta Inc at Stephens Investment Conference Transcript
All right. Good afternoon, I guess now everybody. Welcome to Day 2 of the Stephens conference. I'm Jacob Johnson, the Life Science Tools and Pharma Services Analyst here at Stephens. Really excited to be joined today by Azenta, which I think as it happens 1-year anniversary of announcing the Azenta brand today. So -- it was exciting to talk about last year and some exciting things to talk about today.
We've got CEO, Steve Schwartz; CFO, Lindon Robertson; Sara Silverman from IR who is hanging out in the back, along with Vandana Sriram, the Controller of Azenta. So with that, I will turn it over to Steve or Lindon or both for any opening remarks.
Great. So let me just start off with an overview of our company now. We just finished our fiscal year, and so it's a good time to kind of recapture and as Jacob just highlight, we've been now 1 year into wearing the Azenta name as a stand-alone life science company. Makes us a bit
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |